Literature DB >> 2410095

Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice.

P Ghezzi, M Bianchi, L Gianera, S Landolfo, M Salmona.   

Abstract

Interferon (IFN) and IFN inducers are known to depress hepatic microsomal cytochrome P-450 levels, and the liver toxicity of IFN was reported to be lethal in newborn mice. We have observed that administration to mice of IFN and IFN inducers caused a marked increase in liver xanthine oxidase activity. Because this enzyme is well known to produce reactive oxygen intermediates and cytochrome P-450 was reported to be sensitive to the oxidative damage, we have tested the hypothesis that a free radical mechanism could mediate the depression of cytochrome P-450 levels by IFN. Administration to mice of the IFN inducer polyinosinic-polycytidylic acid (2 mg/kg i.p.) caused a 29 to 52% decrease in liver cytochrome P-450. Concomitant p.o. administration of the free radical scavenger, N-acetylcysteine (as a 2.5% solution in drinking water), or the xanthine oxidase inhibitor, allopurinol (100 mg/kg), protected against the IFN-mediated depression of P-450 kg), protected against the IFN-mediated depression of P-450 levels. The results suggest that an increased endogenous generation of free radicals, possibly due to the induction of xanthine oxidase, is implicated in the IFN-mediated depression of liver drug metabolism. The relevance of these data also extends to cases in which this side effect is observed in pathological situations (e.g., viral diseases and administration of vaccines) associated with an induction of IFN.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410095

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase. Regulation of its transcript by interferons in vivo.

Authors:  M Terao; G Cazzaniga; P Ghezzi; M Bianchi; F Falciani; P Perani; E Garattini
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

2.  Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice.

Authors:  T Akaike; M Ando; T Oda; T Doi; S Ijiri; S Araki; H Maeda
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Effect of hypoxia alone or combined with inflammation and 3-methylcholanthrene on hepatic cytochrome P450 in conscious rabbits.

Authors:  J Kurdi; H Maurice; A O El-Kadi; H Ong; S Dalkara; P M Bélanger; P Souich
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  21-aminosteroids prevent the down-regulation of hepatic cytochrome P450 induced by hypoxia and inflammation in conscious rabbits.

Authors:  A Galal; P Souich
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Differential regulation of cytokine production in lipopolysaccharide tolerance in mice.

Authors:  A Erroi; G Fantuzzi; M Mengozzi; M Sironi; S F Orencole; B D Clark; C A Dinarello; A Isetta; P Gnocchi; M Giovarelli
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  Interferons induce xanthine dehydrogenase gene expression in L929 cells.

Authors:  F Falciani; P Ghezzi; M Terao; G Cazzaniga; E Garattini
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

7.  Role of interleukin-1 in the depression of liver drug metabolism by endotoxin.

Authors:  P Ghezzi; B Saccardo; P Villa; V Rossi; M Bianchi; C A Dinarello
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

8.  Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality.

Authors:  S Gatti; R Faggioni; B Echtenacher; P Ghezzi
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

9.  Depression of liver metabolism and induction of cytokine release by diphtheria and tetanus toxoids and pertussis vaccines: role of Bordetella pertussis cells in toxicity.

Authors:  G Fantuzzi; M Sironi; R Delgado; L Cantoni; M Rizzardini; M Carelli; I Marsili; P Ghiara; P Ghezzi
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

10.  A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion.

Authors:  D Smith; J Wagstaff; N Thatcher; H Scarffe
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.